Euda Health Holdings Limited Revenue Growth Rates (EUDA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Euda Health Holdings Limited  (NASDAQ: EUDA)
 

EUDA's Revenue Growth by Quarter and Year

Euda Health Holdings Limited's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EUDA Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 5.99
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 5.99





EUDA Revenue fourth quarter 2025 Y/Y Growth Comment
Euda Health Holdings Limited achieved in the fourth quarter 2025, above Company average Revenue rise of 59.38% year on year, to $ 5.99 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 24 other companies have achieved higher Revenue growth. While Euda Health Holdings Limited' s Revenue jump of 59.38% ranks overall at the positon no. 383 in the fourth quarter 2025.


EUDA Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 59.38 % 32.39 % -71.14 % -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - -36.33 % -
FY   59.38 % -17.18 % -63.71 % -

Financial Statements
Euda Health Holdings Limited's fourth quarter 2025 Revenue $ 5.99 millions EUDA's Income Statement
Euda Health Holdings Limited's fourth quarter 2024 Revenue $ 3.76 millions Quarterly EUDA's Income Statement


EUDA Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - -82.72 % -
FY (Year on Year)   59.38 % -17.18 % -63.71 % -


Back to EUDA Growth rate Comparisons >> Back to EUDA Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #107
Overall #383

Revenue Y/Y Growth Statistics
High Average Low
32.37 % 32.37 % 32.37 %
(Dec 31 2024)  
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #107
Overall #383
Revenue Y/Y Growth Statistics
High Average Low
32.37 % 32.37 % 32.37 %
(Dec 31 2024)  

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Euda Health Holdings Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EUDA's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EUDA's IV. Quarter Q/Q Revenue Comment


Euda Health Holdings Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
(Dec 31 2024)
Cumulative Revenue 12 Months Ending $ 5.99 $ 0.00 $ 0.00 $ 0.00 $ 3.76
Y / Y Revenue Growth (TTM) 59.29 % - - - 32.37 %
Year on Year Revenue Growth Overall Ranking # 383 # 394 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 59.29 % - - - 32.37 %
Seq. Revenue Growth (TTM) Overall Ranking # 383 # 396 # 0 # 0 # 0


Cumulative Revenue growth Comment
Euda Health Holdings Limited saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 59.29% year on year, to $ 6 millions if the fiscal year would have ended in Dec 31 2025.
Euda Health Holdings Limited's trailing twelve months Revenue growth was higher than company's average 32.37% and higher than % growth in 0.
The momentum is even more impressive from twelve months ended 0 exhibited at 59.29 % increase from $3.76 millions in the period from 0 to Dec 31 2024.

In the Healthcare sector 106 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 383, from total ranking in previous quarter at 394.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 107
Overall # 383

Revenue TTM Y/Y Growth Statistics
High Average Low
32.37 %
 32.37 %
32.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 107
S&P 500 # 383
Cumulative Revenue growth Comment
Euda Health Holdings Limited saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 59.29% year on year, to $ 6 millions if the fiscal year would have ended in Dec 31 2025.
Euda Health Holdings Limited's trailing twelve months Revenue growth was higher than company's average 32.37% and higher than % growth in 0.
The momentum is even more impressive from twelve months ended 0 exhibited at 59.29 % increase from $3.76 millions in the period from 0 to Dec 31 2024.

In the Healthcare sector 106 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 383, from total ranking in previous quarter at 394.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 107
Overall # 383

Revenue TTM Y/Y Growth Statistics
High Average Low
32.37 %
32.37 %
32.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 107
S&P 500 # 383




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EUDA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Phathom Pharmaceuticals Inc 94.12%$ 94.121 millions
Tenon Medical Inc 92.34%$ 92.338 millions
Caribou Biosciences Inc 89.74%$ 89.745 millions
Argenx Se89.08%$ 89.078 millions
Sangamo Therapeutics Inc 88.43%$ 88.425 millions
Agios Pharmaceuticals Inc 86.09%$ 86.086 millions
Oculis Holding Ag85.72%$ 85.722 millions
Alnylam Pharmaceuticals Inc 84.95%$ 84.945 millions
Day One Biopharmaceuticals Inc 83.92%$ 83.915 millions
Neuronetics Inc 82.17%$ 82.169 millions
Arcutis Biotherapeutics Inc 81.48%$ 81.478 millions
Aclarion Inc 80.59%$ 80.590 millions
X4 Pharmaceuticals Inc79.08%$ 79.079 millions
Intellia Therapeutics Inc 78.79%$ 78.787 millions
Envoy Medical Inc 78.57%$ 78.571 millions
Organogenesis Holdings Inc 78.13%$ 78.126 millions
Tg Therapeutics Inc 78.00%$ 78.004 millions
Eton Pharmaceuticals Inc 77.14%$ 77.140 millions
Trisalus Life Sciences Inc 76.95%$ 76.954 millions
Co diagnostics Inc 76.74%$ 76.743 millions
Ss Innovations International Inc76.54%$ 76.537 millions
Cellectis S a 75.76%$ 75.760 millions
Fennec Pharmaceuticals Inc 73.84%$ 73.842 millions
Travere Therapeutics Inc 73.41%$ 73.410 millions
Inspiremd Inc 69.30%$ 69.299 millions
Viridian Therapeutics Inc 68.06%$ 68.056 millions
Sol gel Technologies Ltd 68.04%$ 68.036 millions
Novavax inc 66.61%$ 66.615 millions
Beyond Air Inc 65.61%$ 65.605 millions
Axsome Therapeutics Inc 65.03%$ 65.030 millions


About Euda Health Holdings Limited Revenue Growth Rates (EUDA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Euda Health Holdings Ltd (CIK 1847846).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-019361
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Euda Health Holdings Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.